osteonecrosis of the jaw in patients taking bisphosphonates for osteoporosis

March 2009

You'll hear more controversy about osteonecrosis of the jaw in patients taking bisphosphonates for osteoporosis.

This destruction of the jaw bone was initially seen in patients on high doses of IV bisphosphonates for cancer.

The incidence with ORAL bisphosphonates is much lower...probably less than 0.1%.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote